RBR-6zkm5k
Completed
Phase 4
Acute pancreatitis prevention after endoscopic retrograde cholangiopancreatography (ERCP) with anti-inflammatory
Julio Carlos Pereira Lima0 sitesStarted: December 29, 2015Last updated:
Overview
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Julio Carlos Pereira Lima
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Intervention
Eligibility Criteria
- Ages
- 18Y to 95Y (—)
Inclusion Criteria
- •Eligible subjects were all adults who were scheduled to undergo ERCP at our institution.
Exclusion Criteria
- •Exclusion criteria were patients with known contraindication to ketoprofen use, active pancreatitis at the time of ERCP, previous ERCP and refusal to enter in the study.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Prevention of Acute Pancreatitis after the Endoscopic Cholangiography procedure with the use of the drug IndomethaciOther acute pancreatitispancreatitisCapítulo XIRBR-5g7hghvServiço de Neurorradiologia do Hospital São José do Complexo Hospitalar Santa Casa de Misericórdia de Porto Alegre
Recruiting
Phase 3
Clinical study to verify the effectiveness of two drugs to prevent inflammation of the Pancreas after performing the Endoscopic Retrograde Cholangiopancreatography procedurePancreatitisK85.8RBR-10nnzgqhFaculdade de Medicina de Sao Jose do Rio Preto
Unknown
Phase 1
Prevention of Acute Pancreatitis After Endoscopic InterventionsCholangiolitisAcute PancreatitisNCT04608760Vitebsk State Medical University90
Recruiting
Not Applicable
Prevention of Post-ERCP Pancreatitis by Intraduodenal Indomethacin in ERCP naïve patientsKCT0002394Chung-Ang Univerisity Hospital926
Recruiting
Not Applicable
Prophylaxis of post-ERCP pancreatitis by the intravenous administration of the non-steroidal anti-inflammatory drugPost-ERCP pancreatitisJPRN-UMIN000013193Division of Gastroenterology and Hepatology, Department of Medicine,Nihon University School of Medicine, Tokyo, Japan400